CP-CTNet_LAO-University of Michigan Phase IIA Trial of Acolbifene (20 mg) vs Low Dose Tamoxifen (5 mg) in Pre-menopausal Women at High Risk for Development of Breast Cancer Cancer Prevention and Control CIRB Active Available to Open